Exercise training for intermittent claudication: Does it adversely affect biochemical markers of the exercise-induced inflammatory response?

European Journal of Vascular and Endovascular Surgery

Volumn 14, Issue 5, 1997, Pages 344-350

  Tisi, P V ^a   Hulse, M ^a   Chulakadabba, A ^a   Gosling, P ^a   Shearman, C P ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Exercise; Fibrinogen; Intermittent claudication; Serum amyloid A protein

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; AMYLOID A PROTEIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CREATININE; FIBRINOGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFLAMMATION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; TIME; TREADMILL EXERCISE;

EID: 0030777881     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(97)80283-3     Document Type: Article

References (32)

1. Khaira HS Maxwell SRJ Shearman CP Antioxidant consumption during exercise in intermittent claudication Br J Surg 82 1995 1660 1662
2. Khaira HS Nash GB Bahra PS Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury Eur J Vasc Endovasc Surg 10 1995 31 35
3. Hickey NC Gosling P Baar S Shearman CP Simms MH Effect of surgery on the systemic inflammatory response to intermittent claudication Br J Surg 77 1990 1121 1124
4. Dormandy JA Mahir M Ascady G Fate of the patient with chronic leg ischaemia J Cardiovasc Surg 30 1989 50 57
5. Gown AM Tsukada T Ross R Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions Am J Path 125 1986 191 207
6. Gardner AW Poehlman ET Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis JAMA 274 1995 975 980
7. Leng GC Fowkes FGR The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys J Clin Epidemiol 45 1992 1101 1109
8. Shearman CP Gosling P Simms MH Glomerular permeability to large molecules: a marker of vascular permeability? Br J Surg 75 1988 1273
9. Bland JM Altman DG Calculating correlation coefficients with repeated observations: Part 2 — correlation between subjects Br Med J 310 1995 633
10. Shearman CP Gosling P Gwynn BR Simms MH Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease? Eur J Vasc Surg 2 1988 401 404
11. Bainton D Sweetnam P Baker I Elwood P Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study Br Heart J 72 1994 128 132
12. Dormandy JA Hoare E Khattab AH Arrowsmith DE Dormandy TL Prognostic significance of rheological and biochemical findings in patients with intermittent claudication Br Med J 4 1973 581 583
13. Heinrich J Schulte H Schonfeld R Kohler E Assman G Association of variables of coagulation, fibrinolysis and acutephase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain Thromb Haemost 73 1995 374 379
14. Fowkes FGR Connor JM Smith FB Fibrinogen genotype and risk of peripheral atherosclerosis Lancet 339 1992 693 696
15. Machin SJ Mackie IJ Routine measurement of fibrinogen concentration Br Med J 307 1993 882 883
16. Majewski W Zielinski A Laciak M C-reactive protein and alpha-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs Eur J Vasc Surg 7 1993 623 628
17. Pepys MB Rheumatoid arthritis: the role of acute-phase proteins Br J Rheumatol 32 Suppl. 3 1993 1 2
18. Liuzzo G Biasucci LM Gallimore JR The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina N Engl J Med 331 1994 417 424
19. Meek RL Urieli Shoval S Benditt EP Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function Proc Natl Acad Sci USA 91 1994 3186 3190
20. Kisilevsky R Subrahmanyan L Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function Lab Invest 66 1992 778 785
21. Radack K Wyderski RJ Conservative management of intermittent claudication Ann Int Med 113 1990 135 146
22. Rudofsky G Van Laak HH Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy J Cardiovasc Pharmacol 23 Suppl. 3 1994 S22 S25
23. Larsen OA Lassen NA Effect of daily muscular exercise in patients with intermittent claudication Lancet ii 1966 1093 1095
24. Dahllof AG Holm J Peripheral arterial insufficiency. Effect of physical training on walking tolerance, calf blood flow and blood resistance Scand J Rehab Med 8 1976 19 26
25. Hiatt WR Regensteiner J Hargarten ME Wolfen EE Benefit of exercise conditioning for patients with peripheral arterial disease Circulation 81 1990 602 609
26. Creasy TS McMillan PJ Fletcher EWL Collin J Morris PJ Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial Eur J Vasc Surg 4 1990 135 140
27. Perkins JMT Collin J Creasy TS Fletcher EWL Morris PJ Exercise training versus angioplasty for stable claudication: long and medium term results of a prospective randomised trial Eur J Endovasc Surg 11 1996 409 413
28. Lundgren F Dahllof AG Lundholm K Schersten T Volkmann R Intermittent claudication — surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency Ann Surg 209 1989 346 355
29. Holm J The effect of exercise on intermittent claudication Bell PRF Jamieson CW Ruckley CV Surgical Management of Vascular Diseases 1992 Saunders 111 118
30. Clifford PC Davies PW Hayne JA Baird RN Intermittent claudication: is a supervised exercise class worth while? Br Med J 280 1980 1503 1505
31. Hickey NC Shearman CP Gosling P Simms MH Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria Eur J Vasc Surg 4 1990 603 606
32. Physical Activity Task Force More people, more active, more often: physical activity in England 1995 Department of Health London